CD-39 (Amgen)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCD-39 (Amgen)
Drug Alias NameCD-39 (Immunex)platelet aggregation inhibitor (Amgen)solCD39 (Amgen)CD-39
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEctonucleoside triphosphate diphosphohydrolase 1 agonists
TargetsEctonucleoside triphosphate diphosphohydrolase 1
Therapy Area/IndicationsCoronary Artery DiseaseStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmunex Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmgen IncImmunex Corp
Active IndicationsN/A
Inactive IndicationsCoronary Artery DiseaseStroke

Other Information

ATC CodeN/A
Related LinksN/A